Chemistry in Bioinformatics by Murray-Rust, Peter et al.
BioMed CentralBMC Bioinformatics
ssOpen AcceChemistry in Bioinformatics
Peter Murray-Rust†1, John BO Mitchell†1 and Henry S Rzepa*†2
Address: 1Unilever Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge. CB2 
1EW, UK. and 2Department of Chemistry, Imperial College London, SW7 2AY, UK.
Email: Peter Murray-Rust - pm286@cam.ac.uk; John BO Mitchell - jbom1@cam.ac.uk; Henry S Rzepa* - rzepa@ic.ac.uk
* Corresponding author    †Equal contributors
Abstract
: Chemical information is now seen as critical for most areas of life sciences. But unlike
Bioinformatics, where data is openly available and freely re-usable, most chemical information is
closed and cannot be re-distributed without permission. This has led to a failure to adopt modern
informatics and software techniques and therefore paucity of chemistry in bioinformatics. New
technology, however, offers the hope of making chemical data (compounds and properties) free
during the authoring process. We argue that the technology is already available; we require a
collective agreement to enhance publication protocols.
Introduction
In "Representation and Use of Chemistry in the Global
Electronic Age” [1] we showed that new technology can
provide great increases in the quantity and quality of
aggregated chemical information published in the pri-
mary literature. We also argued the benefits of Open
Access and Open Data. The current invited overview and
a parallel technical article extends the same methodology
to chemistry in bioinformatics to remove the loss and cor-
ruption of data that occurs in current publishing. We are
pleased that this article is an Open Access publication, and
we expect that bioinformatics, with its culture of Open
Data, is more likely than mainstream chemistry to adopt
new approaches. The benefits of open access  include
higher quality, greater availability, and development of
the Biochemical Semantic Web where robots mine text
and data as a basis for knowledge-driven science. We
argue that funders, institutions, authors, editors, publish-
ers and readers will all benefit.
Biosciences now require large amounts of detailed chem-
ical information, examples of which include the  occur-
rence and role of small-molecules in biological processes;
the mechanism of biochemical reactions and interactions;
the structure and properties of biomolecules; reagents,
protocols and classificatory tools for performing bio-
science; chemistry in the ecosphere. Such information is
only available in a dispersed manner in the primary liter-
ature and current mechanisms for its collection and dis-
semination do not meet the needs of bioscience. However
if there is a communal will, modern chemical informatics
technology can provide what is required. Several excellent
models for the capture of macromolecular sequence and
structure data (e.g. the protein data bank) inform our
architecture.
Data in published articles can include reference to chemi-
cal compounds (often in free text), details of their synthe-
sis (in vivo and in vitro), proof of their structure (spectra
and analytical data), methods and reagents in bioscience
protocols, the physical and biological properties and reac-
tion of compounds both in enzymes and enzyme-free sys-
tems. With the tools that we and others have developed,
this information can now be automatically captured with
high precision from primary publications, especially if
structured authoring tools are widely used.
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text-mining tools in their research, conventional chemists
appear culturally more suspicious of robotic data extrac-
tion and continue to rely on manually curated secondary
publications whose philosophy has barely altered over
120 years. Such sources are necessarily incomplete in
time, coverage and coverage of information types. For
example for 99+% of all newly synthesised compounds
the papers report that Infra-red spectra have been
recorded, but only a tiny fraction of this is available in
electronic form. We argue that even modest improvement
in such a data capture rate would make an enormous dif-
ference. Moreover the data would be of consistently
higher quality than manually re-keyed data. The main
challenge is a cultural one. Thus biosciences and crystal-
lography have communally convinced authors and pub-
lishers of the value of author-based deposition of data,
later aggregated in communally accessible databanks. This
largely does not currently happen in chemistry, where
information is manually extracted from the primarily lit-
erature, jealously guarded and sold back to the commu-
nity. Mechanisms such as "supporting or supplemental
data deposition" are not widely used, and when they are,
little care is given to enabling its re-use. One of the major
secondary publishers has recently criticised the bioscience
community for aggregating chemical data. 
"It [PubChem] would not only injure us significantly, it would
put information for free in the hands of world scientists and do
it all with taxpayer money," Massie [CEO, Chemical Abstract
Service] said. "For me to wake up one morning and find I have
to compete with my own government is extraordinary.”[2]
The attitude in chemistry to modern informatics (XML,
ontologies, RDF, text-mining, metadata, etc.) [3] is largely
apathetic, with some data- or software-centric organisa-
tions actively opposing interoperability for commercial
reasons. This problem extends to mainstream chemical
software, where there are no Open standards and where
algorithms are closed and obscure. We have argued that
the large data aggregators produce vendor-centric access
systems to meet their needs rather than the community's.
Another problem is that access is often only allowable on
a per-item basis rather than to the data collection as a
whole. This monopolistic "thought control" in chemistry
stifles innovation in data-led science. However the Opens
(Data, Source, Access, Standards) are changing the prac-
tice of scientific informatics and chemistry is starting to be
affected.
We therefore look to bioscience to take a lead in helping
realise the following vision. We now believe that there are
already enough Open tools and Open resources which
can make the vision attractive and cost-effective.
A model for automatic capture of chemical information
Much chemical data is largely context-free in that it can be
understood and recreated independently of the location
or motivation. The primary data model, inspired by Kon-
rad Beilstein in the 19th century, has three components:
compound, properties and citations. A pure compound is
described by an immutable structural formula and has
precisely reproducible properties. Current thinking asserts
that the biological action of a compound is, in principle,
reproducible and predictable if the system is carefully
enough replicated and the components understood. This
is the central dogma of the chemically-based pharmaceu-
tical industry and the chemical information industry on
which it relies.
Chemistry has a tradition of ensuring quality through
reporting properties and analysis, so every new com-
pound (and many re-synthesised ones) must have pub-
lished measurements of properties to justify their identity
and purity. These facts are available, in text form, in the
primary literature in which over a million new com-
pounds are published annually. Because structure predicts
properties, and because drug discovery is so difficult, the
pharmaceutical industry tests many compounds for bio-
logical activity. The data in these public publications is a
major feedstock for the chemical information industry.
The chemical bioscientist has almost all of the required
information available in electronic form on their bench-
top already! It could be deposited for the scientific com-
munity with virtually no human intervention. We believe
that, with the help of forward looking publishers, a work-
ing protocol can be set up in bioscience, which will then
inspire (or terrify) mainstream chemical informatics.
Note that much of the information captured is additional
to that which the current abstracters collect.
We argue that the key components to automatically cap-
ture chemical information are already in place (and are
discussed in more detail in an accompanying technical
article). We envisage the chemistry which can be captured
using such mechanisms includes (a) Chemical entities
and names. Many compounds have no explicit structures
and are mentioned only by name or identifiers. Where
these relate to specific compounds it is valuable to link
them to a precise identification, such as PubChem. (b)
Molecular structure, expressed as a compositional for-
mula (e.g. CHaOH for methanol) and a graphical struc-
tural formula ("2D diagram" or connection table). (c)
Spectra and physical properties. Much such information is
already in digital form when produced by instruments
(whose manufacturers are starting to create Open
approaches [4], but is largely destroyed by conventional
publishing processes If a community-wide digital tem-
plate for the submission of this information were availa-Page 2 of 4
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by many, would eliminate errors introduced by transcrip-
tion, and enable machine-reviewing of data leading to a
higher standard of published data.
The basis of our model involves conversion of experimen-
tal data to XML and its merger with the conventional text
(giving a “datument” [5]). The author uses a authoring
tool which can manage structured XML documents and
provide normal textual support (spellchecks, etc.). The
resulting datument contains fine-grained markup of facts
(molecules, measurements, properties, chemical names)
and can automatically be used to create derivatives such as
the "full-text" or the "supplemental data". The complete
datument, if Open, or the "data" if not is then reposited
for further harvesting. All compound/property data is
available for datamining and computational re-use (e.g.
for further in silico prediction.
Realising the vision
Data repositing and maintenance
The current dissemination of data through publishers is
largely unsatisfactory.   Thus although many publishers
allow the deposition of factual "supplementary data”,  our
experience with most is that it is an unwelcome chore,
poorly resourced and maintained. Moreover although
reviewers are often do what they can to validate data, pub-
lishers themselves do not. We believe that many publish-
ers would welcome a model where they were no longer
involved in data repositing. A few publishers such as the
International Union of Crystallography are more commit-
ted to the curation of data; others in the biosciences see
the value of semantically enhanced data.The crystallo-
graphic experience has shown that expert computer pro-
grams can act as powerful reviewers complementing the
human; automatic curation enhances, rather than lowers,
data quality.
Our model is based on the availability of repositories, pri-
marily Institutional, that accept data as well as full text.
Already some academic institutions and an increasing
number of funders mandate that research output should
be reposited and there are national initiatives to develop
the infrastructure. The storage for XML-ised chemical data
is modest (less than 1 mbyte per publication) and we have
shown that large numbers of molecules can be deposited
in our own institutional repository [6] and recovered by
undirected search engines such as Google [7]. Chemical
data has required no semantic maintenance (e.g. through
changes in meaning or use) over many decades and we see
this continuing, so that the maintenance costs are those
general to any repository.         
Components in a repository have a unique handle with
which,  in principle, a Digital object or other identifier
(DOI) [8] can be associated so that data can be cloned for
access and preservation. The handle or DOI would be
published in the "full text" and would bind the data to it
more effectively that at present and hopefully indefinitely.
Metadata
Through the InChI (International Chemical Identifier)[8]
and a controlled vocabulary of chemical properties,
generic search engines can achieve a very high degree of
recall. This means that discovery and aggregation can be
built on maintenance-free generic technology and can be
made completely automatic, Conventionalists would
argue of course that human curation is essential for re-usa-
ble chemical data. In a similar vein to much bioinfor-
matic, we argue that robots can discover patterns in data,
compounds and authors which are at least as powerful as
many current abstracting services. Where human evalua-
tion is critical (e.g. in human medicine, patents, etc.) then
the robots will provide the primary resources on which a
judgement can be based.
Rights
We assume that most bioscience authors and publishers
will agree that whether or not a paper is Open Access the
facts (and thereby all "supplemental data") therein are
not copyrightable. XML resolves differences of interpreta-
tion in that XML markup can be regarded as identifying
factual information and this would be consistent with its
re-use under (say) the Budapest Open Access Initiative. In
this way all published chemical data can be made imme-
diately, completely and clearly available for indefinite sci-
entific re-use.
Potential
Because the chemical information is structured we now
have a biocheminformatics "cycle" where, for the first
time, large scale robotic data analysis can take place. The
data in the research (laboratory, in silico, or both) are
published in a lossless manner. Molecules and their prop-
erties have unique identifiers as described above and can
be integrated into mainstream bioinformatics in the same
manner as collections such as PubChem, the macromo-
lecular stucture database (MSD at EBI), the Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) etc.  They will bring
the added value of consistently captured property data
and spectra. We also expect that many  in silico properties
will then be systematically added.
Author and publisher compliance
The introduction of structured authoring tools (e.g. Publi-
con) [9] will help this process considerably. Templates
can be created for the chemical components described
above and where the information exists in XML (connec-
tion tables, spectra, properties) it should be as easy as for
committed authors as using a semantically void tool (e.g.Page 3 of 4
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Word). Where information needs to be converted from
legacy formats, an increasing number of open Web Serv-
ices,  which publishers (and authors) may clone and cus-
tomise are becoming avilable. We expect authors to have
a greater incentive (even if only through mandation) to
reposit data and to disseminate research findings. This
also raises the vision of changing the "citation economy"
(which values market perception) to a "reuse economy"
where a the data in a paper are valued by how often they
are re-used.
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